• On The Case

    Clues For Identifying and Treating Retinal Vascular Disease

    Read Issue
  • Treat & Extend Regimen For nAMD

    Read Article
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • AMD Disease Education Resource Center
  • Articles From This Issue



    Medical Editor’s Page

    Something For Everyone

    FOUR FAVORITES Retina Today’s choice takeaways from this issue. “After ERM surgery, the macula rarely returns to its original shape, even after months or y…


    Aflibercept Improved DR Severity Score at 6 Months in Patients with NPDR In a phase 3 clinical trial, 58% of patients with nonproliferative diabetic retinopathy (NPDR) treated w…


    Coding Advisor

    Get Familiar With Payer Audits

    Every payer conducts audits. Given the number of types of audits, the diverse areas they target, and their randomness, the sad reality is that it would be rare for a physician …


    Supplements and Inserts

    CME-1 Credit

    AMD in 2017: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

    CME-1 Credit

    Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing



    Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

    Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for us…

    GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

    GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sham-treated eyes demonstra…

    Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes

    A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endothelial growth factor (VEGF) i…

    Patients Regain Sight After Being First to Get Retinal Tissue Engineered From Stem Cells

    The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision, according to a report in VisionMonday. Th…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman

    Janet Burk

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.